Liberty Wealth Management LLC Ligand Pharmaceuticals Inc Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$127.69 - $165.85 $893 - $1,160	-7 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$113.03 - $155.64 $102,970 - $141,788	-911 Reduced 99.24%	7 $1,000
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $102,970 - $141,788	911 Added 13014.29%	918 $7,000
Q1 2019 Apr 18, 2019	BUY	$105.93 - $142.47 $741 - $997	7 New	7 $0

275

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.04B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.